AACR 2026: Early Clinical Activity and Tumor Transcriptional Modulation of AU409, a First-in-Class Transcription Regulator, in Advanced Solid Tumors and Hepatocellular Carcinoma Jul 29 Written by Jingyu Guo Jingyu Guo Next Next Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
AACR 2026: Early Clinical Activity and Tumor Transcriptional Modulation of AU409, a First-in-Class Transcription Regulator, in Advanced Solid Tumors and Hepatocellular Carcinoma Jul 29 Written by Jingyu Guo Jingyu Guo
